Determinants of hydroxyurea use among doctors, nurses and sickle cell disease patients in Nigeria.

ABSTRACT:

Background

Hydroxyurea (HU) is an evidence-based therapy that is currently the most effective drug for sickle cell disease (SCD). HU is widely used in high-income countries with consequent reduction of morbidity and mortality. In Nigeria, HU is prescribed by physicians while nurses are mainly involved in counseling the patients to ensure adherence. The extent of utilization and the determinant factors have not been sufficiently evaluated in Nigeria.

Objective

To assess the frequency of use of HU and factors affecting utilization among healthcare providers, patients, and caregivers for SCD.

Methods

A questionnaire was administered online and in- person to assess the frequency of HU use and the factors that promote and limit its use. The data were analyzed by descriptiv

SUBMITTER: Isa HA 

PROVIDER: S-EPMC9682971 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature